SUBSCRIBE
SUBSCRIBE
BioForest

TapImmune Inc. Provides Shareholder Update

October 1, 2009 | 
1 min read

BELLEVUE, Wash., Oct. 1, 2009 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases, provides this corporate update.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: 3D rendering of antibody-drug conjugate/
BioForest
ADC-Focused ProfoundBio Raises $112M in Oversubscribed Series B
February 14, 2024
 · 
2 min read
 · 
Tyler Patchen
A moving truck parked in San Francisco’s Nob Hill
BioForest
How the Pandemic Shifted the Rules of Recruiting
October 25, 2023
 · 
4 min read
 · 
Amanda Heidt
2023 Hotbed Maps
Bio NC
BioSpace Releases Exclusive Hotbed Maps
January 5, 2023
 · 
4 min read
 · 
Lisa Munger